Emulate Organ-Chip Platform is an organ-on-a-chip system for human-relevant preclinical drug testing.
Emulate's Organ-Chip platform grows human cells in lined microfluidic channels under perfusion and stretch to recreate organ-level physiology and mechanical forces in vitro. Pharmaceutical and biotech researchers use the chips with the company's instrumentation and software to predict human responses to drugs, chemicals and foods.
The platform spans organ models across liver, kidney, lung, intestine, brain and vasculature, and supports higher-throughput formats. It is positioned as an alternative to animal testing and conventional 2D cell culture for preclinical efficacy and safety studies.
| Attribute | Emulate Organ-Chip Platform | OrganoAccess, OrganoPlate | ParVivo Platform | |
|---|---|---|---|---|
| Provider | |  |  | |
| Founded | 2013 | 2013 | 2007 | |
| Sells To | Enterprise, Government | Pharmaceutical Manufacturers | Enterprise | |
| Pricing Model | Recurring, Software, Transactional | Product Sales, Service Fees | Recurring | |
| Ownership | Private, Venture-backed | Private | Venture-backed |
Provider
Founded 2013
Sells To Enterprise, Government
Pricing Model Recurring, Software, Transactional
Ownership Private, Venture-backed
Provider
Founded 2013
Sells To Pharmaceutical Manufacturers
Pricing Model Product Sales, Service Fees
Ownership Private
Provider
Founded 2007
Sells To Enterprise
Pricing Model Recurring
Ownership Venture-backed
OrganoPlate Platform is MIMETAS's high-throughput organ-on-a-chip system for 3D human tissue models.
PhysioMimix is CN Bio's organ-on-a-chip microphysiological system for preclinical drug discovery.
OrganoReady is MIMETAS' ready-to-use Assay Ready tissue model product line for organ-on-a-chip drug testing.
Patient-Derived Organoid Platform is the primary commercial offering marketed by Xilis to its core customer segments.
OrganoPlate Platform is MIMETAS's high-throughput organ-on-a-chip system for 3D human tissue models.
PhysioMimix is CN Bio's organ-on-a-chip microphysiological system for preclinical drug discovery.
OrganoReady is MIMETAS' ready-to-use Assay Ready tissue model product line for organ-on-a-chip drug testing.
Patient-Derived Organoid Platform is the primary commercial offering marketed by Xilis to its core customer segments.
